Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
24.47
+4.03 (19.72%)
At close: Oct 8, 2025, 4:00 PM EDT
24.51
+0.04 (0.16%)
After-hours: Oct 8, 2025, 6:13 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Genome Editing-based Therapies
57.88M
Log In
Log In
Log In
Log In
Upgrade
Genome Editing-based Therapies Growth
59.55%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
57.88M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
59.55%
Log In
Log In
Log In
Log In
Upgrade